FAKTOR OPTIONSSCHEIN - INCYTE CO. Stock

DE000GX55AJ9

Real-time BOERSE MUENCHEN 03:02:29 2024-07-04 EDT
5.198 ^EUR	0.00%

Current month	-10.08%
1 month	-4.22%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

S&P 500, Nasdaq Close at Record Highs After Fed Chair Powell's Comments	07-02	MT
S&P 500, Nasdaq Close at Record Highs After Fed Chair Powell's Comments	07-02	MT
Sector Update: Health Care Stocks Retreat Tuesday Afternoon	07-02	MT
Incyte Shares Fall Following BMO Capital Downgrade	07-02	MT

More news

Quotes 5-day view

Date	Price	Change
24-07-04	5.198	0.00%
24-07-03	5.198	-5.88%
24-07-02	5.523	-5.05%
24-07-01	5.817	+0.62%
24-06-28	5.781	-2.45%

Real-time BOERSE MUENCHEN

Last update July 04, 2024 at 03:02 am

More quotes

Static data

Product type	Produits Exotiques
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Goldman Sachs
WKN	GX55AJ
ISIN	DE000GX55AJ9
Date issued	2021-12-06
Strike	29.51 $
Maturity	Unlimited
Parity	5.04 : 1
Emission price	9.94 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	16.28 €
Lowest since issue	4.173 €
Spread	0.02 €
Spread %	0.38%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.66 USD

Average target price

72.62 USD

Spread / Average Target

+25.94%

Consensus